Mechanical versus biological aortic valve replacement strategies

References

• Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J. 2012;33:2451–2496.
   PubMed Web of Science ®Google Scholar
• Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the american college of cardiology/american heart association task force on practice guidelines. Circulation. 2014;129:521–643.
   PubMed Web of Science ®Google Scholar
• Bourguignon T, Bouquiaux-Stablo A-L, Candolfi P, et al. Very long-term outcomes of the carpentier-edwards perimount valve in aortic position. Ann Thorac Surg. 2015;99:831–837.
   PubMed Web of Science ®Google Scholar
• Johnston DR, Soltesz EG, Vakil N, et al. Long-term durability of bioprosthetic aortic valves: implications from 12,569 implants. Ann Thorac Surg. 2015;99:1239–1247.
   PubMed Web of Science ®Google Scholar
• Di Eusanio M, Saia F, Pelliciari G, et al. In the era of the valve-in-valve: is transcatheter aortic valve implantation (TAVI) in sutureless valves feasible? Ann Cardiothorac Surg. 2015;4:214–217.
   PubMedGoogle Scholar
• Duncan A, Davies S, Di Mario C, et al. Vavle-in-valve transcatheter aortic valve implantation for failing surgical aortic stentless bioprosthetic valves: A singlee-center experience. J Thorac Cardiovasc Surg. 2015;150:91–98.
   PubMed Web of Science ®Google Scholar
• Gurvitch R, Cheung A, Ye J, et al. Transcatheter valve-in-valve implantation for failed surgical bioprosthetic valves. J Am Coll Cardiol. 2011;58:2196–2209.
   PubMed Web of Science ®Google Scholar
• Conradi L, Silaschi M, Seiffert M, et al. Transcatheter valve-in-valve therapy using 6 different devices in 4 anatomic positions: Clinical outcomes and technical considerations. J Thorac Cardiovasc Surg. 2015;150:1557–1567.
   PubMed Web of Science ®Google Scholar
• Barbanti M, Petronio AS, Ettori F, et al. 5-year outcomes after transcatheter aortic valve implantation with corevalve prosthesis. JACC Cardiovasc Interv. 2015;8:1084–1091.
   PubMed Web of Science ®Google Scholar
• Grant SW, Hickey GL, Ludman P, et al. Activity and outcomes for aortic valve implantations performed in England and Wales since the introduction of transcatheter aortic valve implantation. Epub: Eur J Cardiothorac Surg. 2015 Aug. doi:10.1093/ejcts/ezv270.
   Google Scholar
• Bourguignon T, Bergöend E, Mirza A, et al. Risk factors for valve-related complications after mechanical heart valve replacement in 505 patients with long-term follow up. J Heart Valve Dis. 2011;20:673–680.
   PubMed Web of Science ®Google Scholar
• Oxenham H, Bloomfield P, Wheatley DJ, et al. Twenty year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses. Heart. 2003;89:715–721.
   PubMed Web of Science ®Google Scholar
• Birkmeyer NJ, Birkmeyer JD, Tosteson AN, et al. Prosthetic valve type for patients undergoing aortic valve replacement: a decision analysis. Ann Thorac Surg. 2000;70:1946–1952.
   PubMed Web of Science ®Google Scholar
• Hammermeister K, Sethi GK, Henderson WG, et al. Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the veterans affairs randomized trial. J Am Coll Cardiol. 2000;36:1152–1158.
   PubMed Web of Science ®Google Scholar
• Wieloch M, Själander A, Frykman V, et al. Anticoagulation control in Sweden: reports of time in therapeutic range, major bleeding, and thrombo-embolic complications from the national quality registry AuriculA. Eur Heart J. 2011;32:2282–2289.
   PubMed Web of Science ®Google Scholar
• Heneghan C, Ward A, Perera R, et al. Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data. Lancet. 2012;379:322–334.
   PubMed Web of Science ®Google Scholar
• Eikelboom JW, Connolly SJ, Brueckmann M, et al. Dabigatran versus warfarin in patients with mechanical heart valves. NEJM. 2013;369:1206–1214.
   PubMed Web of Science ®Google Scholar
• Stewart S, Hart CL, Hole DJ, et al. Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study. Heart. 2001;86:516–521.
   PubMed Web of Science ®Google Scholar
• Heeringa J, van der Kuip D, Hofman A, et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J. 2006;27:949–953.
   PubMed Web of Science ®Google Scholar
• Stassano P, Di Tommaso L, Monaco M, et al. Aortic valve replacement: a prospective randomized evaluation of mechanical versus biological valves in patients ages 55 to 70 years. J Am Coll Cardiol. 2009;54:1862–1868.
   PubMed Web of Science ®Google Scholar
• Brown ML, Schaff HV, Lahr BD, et al. Aortic valve replacement in patients aged 50 to 70 years: improved outcome with mechanical versus biologic prostheses. J Thorac Cardiovasc Surg. 2008;135:878–884.
   PubMed Web of Science ®Google Scholar
• Weber A, Noureddine H, Englberger L, et al. Ten-year comparison of pericardial tissue valves versus mechanical prostheses for aortic valve replacement in patients younger than 60 years of age. J Thorac Cardiovasc Surg. 2012;144:1075–1083.
   PubMed Web of Science ®Google Scholar
• Glaser N, Jackson V, Holzmann MJ, et al. Aortic valve replacement with mechanical vs. biological prostheses in patients aged 50-69 years. Epub: Eur Heart J. 2015 Nov. doi:10.1093/eurheartj/ehv580.
   Google Scholar
• Habib G, Thuny F, Avierinos J. Prosthetic valve endocarditis: current approach and therapeutic options. Prog Cardiovasc Dis. 2008;50:274–281.
   PubMed Web of Science ®Google Scholar
• Brennan JM, Edwards FH, Zhao Y, et al. Long-term safety and effectiveness of mechanical versus biologic aortic valve prostheses in older patients: results from the society of thoracic surgeons adult cardiac surgery national database. Circulations. 2013;127:1647–1655.
   PubMed Web of Science ®Google Scholar
• Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the committee on rheumatic fever, endocarditis, and kawasaki disease, council on cardiovascular disease in the young, and the councils on clinical cardiology, stroke, and caridovascular surgery and anesthesia, american heart association: endorsed by the infectious diseases society of America. Circulation. 2005;111:394–434.
   PubMed Web of Science ®Google Scholar
• Nguyen DT, Delahaye F, Obadia JF, et al. Aortic valve replacement for active infective endocarditis: 5-year survival comparison of bioprostheses, homografts and mechanical prostheses. Eur J Cardiothorac Surg. 2010;37:1025–1032.
   PubMed Web of Science ®Google Scholar
• Moon MR, Miller DC, Moore KA, et al. Treatment of endocarditis with valve replacement: the question of tissue versus mechanical prosthesis. Ann Thorac Surg. 2001;71:1164–1171.
   PubMed Web of Science ®Google Scholar
• Massel DR, Little SH. Antiplatelet and anticoagulation for patients with prosthetic heart valves. Cochrane Database Syst Rev. 2013;7:CD003464.
   PubMedGoogle Scholar
• Altman R, Rouvier J, Gurfinkel E, et al. Comparison of two levels of anticoagulant therapy in patients with substitute heart valves. J Thorac Cardiovasc Surg. 1991;101:427–431.
   PubMed Web of Science ®Google Scholar
• Elkayam U, Bitar F. Valvular heart disease and pregnancy. Jacc. 2005;46:403–410.
   Web of Science ®Google Scholar
• Lawley CM, Lain SJ, Algert CS, et al. Prosthetic heart valves in pregnancy, outcomes for women and their babies: a systematic review and meta-analysis. BJOG. 2015;122:1446–1455.
   PubMed Web of Science ®Google Scholar
• Oakley C, Child A, Lung B, et al. Task force on the management of cardiovascular diseases during pregnancy of the european society of cardiology. Eur Heart J. 2003;24:761–781.
   PubMed Web of Science ®Google Scholar
• Larrea JL, Nuñez L, Reque JA, et al. Pregnancy and mechanical valve prostheses: a high-risk situation for the mother and the fetus. Ann Thorac Surg. 1983;36:459–463.
   PubMed Web of Science ®Google Scholar
• Mihaljevic T, Paul S, Leacche M, et al. Valve replacement in women of childbearing age: influences on mother, fetus and neonate. J Heart Valve Dis. 2005;14:151–157.
   PubMed Web of Science ®Google Scholar
• von Hagen IM, Roos-Hesselink JW, Ruys TP, et al. Pregnancy in women with a mechanical heart valve: data of the european society of cardiology registry of pregnancy and cardiac disease (ROPAC). Circulation. 2015;132:132–142.
   PubMed Web of Science ®Google Scholar
• Chan V, Jamieson WRE, Fleisher AG, et al. Valve replacement surgery in end-stage renal failure: mechanical prostheses versus bioprostheses. Ann Thorac Surg. 2006;81:857–862.
   PubMed Web of Science ®Google Scholar
• Boening A, et Brück M. Heart valve prosthesis selection in patients with end-stage renal disease requiring dialysis: a systematic review and meta-analysis. Heart. 2012;98:99.
   PubMed Web of Science ®Google Scholar
• Okada N, Tajima K, Takami Y, et al. Valve selection for the aortic position in dialysis patients. Ann Thorac Surg. 2015;99:1524–1531.
   PubMed Web of Science ®Google Scholar
• Pai VB, Tai CK, Bhakri K, et al. Should we use mechanical valves in patients with end-stage renal disease? Interact Cardioasc Thorac Surg. 2012;15:240–243.
   PubMed Web of Science ®Google Scholar
• Puskas J, Gerdisch M, Nichols D, et al. Reduced anticoagulation after mechanical aortic valve replacement: interim results from the prospective randomized on-X valve anticoagulation clinical trial randomized Food and Drug Administration investigational device exemption trial. J Thorac Cadiovasc Surg. 2014;147:1202–1210.
   PubMed Web of Science ®Google Scholar
• Gallegos R, Rivard A, Suwan P, et al. In-vivo experience with the Triflo trileaflet mechanical heart valve. J Heart Valve Dis. 2006;15:791–799.
   PubMed Web of Science ®Google Scholar
• Chan WS, Anand S, Ginsberg JS. Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Arch Intern Med. 2000;160:191–196.
   PubMedGoogle Scholar
• Li T, Lai Y, Bian C, et al. Meta-analyses of pregnancy outcomes in women with mechanical heart valves treated by different anticoagulant regimens. J EvidBased. 2008;8:42–48.
   Google Scholar
• Mol A, Smits A, Bouten C, et al. Tissue engineering of heart valves: advances and current challenges. Expert Rev Med Devices. 2009;6:259–275.
   PubMed Web of Science ®Google Scholar
• Driessen-Mol A, Emmert M, Dijkman P, et al. Transcatheter implantation of homologous ‘off-the-shelf’ tissue-engineered heart valves with self-repair capacity: long-term functionality and rapid in vivo remodeling in shee. J Am Coll Cardiol. 2014 Apr 8;63:1320–1329.
   PubMed Web of Science ®Google Scholar